School of Engineering Archives

November 13, 2025

New lightweight polymer film can prevent corrosion

MIT researchers have developed a lightweight polymer film that is nearly impenetrable to gas molecules, raising the possibility that it could be used as a protective coating to prevent solar cells and other infrastructure from corrosion, and to slow the aging of packaged food and medicines.

The polymer, which can be applied as a film mere nanometers thick, completely repels nitrogen and other gases, as far as can be detected by laboratory equipment, the researchers found. That degree of impermeability has never been seen before in any polymer, and rivals the impermeability of molecularly-thin crystalline materials such as graphene.

“Our polymer is quite unusual. It’s obviously produced from a solution-phase polymerization reaction, but the product behaves like graphene, which is gas-impermeable because it’s a perfect crystal. However, when you examine this material, one would never confuse it with a perfect crystal,” says Michael Strano, the Carbon P.

» Read More

November 11, 2025

Leading quantum at an inflection point

Danna Freedman is seeking the early adopters.

She is the faculty director of the nascent MIT Quantum Initiative, or QMIT. In this new role, Freedman is giving shape to an ambitious, Institute-wide effort to apply quantum breakthroughs to the most consequential challenges in science, technology, industry, and national security.

The interdisciplinary endeavor, the newest of MIT President Sally Kornbluth’s strategic initiatives, will bring together MIT researchers and domain experts from a range of industries to identify and tackle practical challenges wherever quantum solutions could achieve the greatest impact.

“We’ve already seen how the breadth of progress in quantum has created opportunities to rethink the future of security and encryption, imagine new modes of navigation, and even measure gravitational waves more precisely to observe the cosmos in an entirely new way,” says Freedman, the Frederick George Keyes Professor of Chemistry.

» Read More

November 10, 2025

Charting the future of AI, from safer answers to faster thinking

Adoption of new tools and technologies occurs when users largely perceive them as reliable, accessible, and an improvement over the available methods and workflows for the cost. Five PhD students from the inaugural class of the MIT-IBM Watson AI Lab Summer Program are utilizing state-of-the-art resources, alleviating AI pain points, and creating new features and capabilities to promote AI usefulness and deployment — from learning when to trust a model that predicts another’s accuracy to more effectively reasoning over knowledge bases. Together, the efforts from the students and their mentors form a through-line, where practical and technically rigorous research leads to more dependable and valuable models across domains.

Building probes, routers, new attention mechanisms, synthetic datasets, and program-synthesis pipelines, the students’ work spans safety, inference efficiency, multimodal data, and knowledge-grounded reasoning. Their techniques emphasize scaling and integration, with impact always in sight.

Learning to trust, and when

MIT math graduate student Andrey Bryutkin’s research prioritizes the trustworthiness of models.

» Read More

November 9, 2025

Particles that enhance mRNA delivery could reduce vaccine dosage and costs

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.

In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.

“One of the challenges with mRNA vaccines is the cost,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES). “When you think about the cost of making a vaccine that could be distributed widely, it can really add up. Our goal has been to try to make nanoparticles that can give you a safe and effective vaccine response but at a much lower dose.”

While the researchers used their particles to deliver a flu vaccine,

» Read More

November 5, 2025

Teaching robots to map large environments

A robot searching for workers trapped in a partially collapsed mine shaft must rapidly generate a map of the scene and identify its location within that scene as it navigates the treacherous terrain.

Researchers have recently started building powerful machine-learning models to perform this complex task using only images from the robot’s onboard cameras, but even the best models can only process a few images at a time. In a real-world disaster where every second counts, a search-and-rescue robot would need to quickly traverse large areas and process thousands of images to complete its mission.

To overcome this problem, MIT researchers drew on ideas from both recent artificial intelligence vision models and classical computer vision to develop a new system that can process an arbitrary number of images. Their system accurately generates 3D maps of complicated scenes like a crowded office corridor in a matter of seconds.

» Read More

November 4, 2025

A new patch could help to heal the heart

MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help promote healing and regeneration of cardiac tissue.

The new patch is designed to carry several different drugs that can be released at different times, on a pre-programmed schedule. In a study of rats, the researchers showed that this treatment reduced the amount of damaged heart tissue by 50 percent and significantly improved cardiac function.

If approved for use in humans, this type of patch could help heart attack victims recover more of their cardiac function than is now possible, the researchers say.

“When someone suffers a major heart attack, the damaged cardiac tissue doesn’t regenerate effectively, leading to a permanent loss of heart function. The tissue that was damaged doesn’t recover,” says Ana Jaklenec, a principal investigator at MIT’s Koch Institute for Integrative Cancer Research.

» Read More

November 2, 2025

Injectable antenna could safely power deep-tissue medical implants

Researchers from the MIT Media Lab have developed an antenna — about the size of a fine grain of sand — that can be injected into the body to wirelessly power deep-tissue medical implants, such as pacemakers in cardiac patients and neuromodulators in people suffering from epilepsy or Parkinson’s disease.

“This is the next major step in miniaturizing deep-tissue implants,” says Baju Joy, a PhD student in the Media Lab’s Nano-Cybernetic Biotrek research group. “It enables battery-free implants that can be placed with a needle, instead of major surgery.”

A paper detailing this work was published in the October issue of IEEE Transactions on Antennas and Propagation. Joy is joined on the paper by lead author Yubin Cai, PhD student at the Media Lab; Benoît X. E. Desbiolles and Viktor Schell, former MIT postdocs; Shubham Yadav, an MIT PhD student in media arts and sciences;

» Read More

November 1, 2025

New nanoparticles stimulate the immune system to attack ovarian tumors

Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian cancer.

To elicit a better response, MIT researchers have designed new nanoparticles that can deliver an immune-stimulating molecule called IL-12 directly to ovarian tumors. When given along with immunotherapy drugs called checkpoint inhibitors, IL-12 helps the immune system launch an attack on cancer cells.

Studying a mouse model of ovarian cancer, the researchers showed that this combination treatment could eliminate metastatic tumors in more than 80 percent of the mice. When the mice were later injected with more cancer cells, to simulate tumor recurrence, their immune cells remembered the tumor proteins and cleared them again.

“What’s really exciting is that we’re able to deliver IL-12 directly in the tumor space.

» Read More

October 31, 2025

Using classic physical phenomena to solve new problems

Quenching, a powerful heat transfer mechanism, is remarkably effective at transporting heat away. But in extreme environments, like nuclear power plants and aboard spaceships, a lot rides on the efficiency and speed of the process.

It’s why Marco Graffiedi, a fifth-year doctoral student at MIT’s Department of Nuclear Science and Engineering (NSE), is researching the phenomenon to help develop the next generation of spaceships and nuclear plants.

Growing up in small-town Italy

Graffiedi’s parents encouraged a sense of exploration, giving him responsibilities for family projects even at a young age. When they restored a countryside cabin in a small town near Palazzolo, in the hills between Florence and Bologna, the then-14-year-old Marco got a project of his own. He had to ensure the animals on the property had enough accessible water without overfilling the storage tank. Marco designed and built a passive hydraulic system that effectively solved the problem and is still functional today.

» Read More

October 29, 2025

New method could improve manufacturing of gene-therapy drugs

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits their availability for those who need them. Part of the reason for the cost is that the manufacturing process yields as much as 90 percent non-active material, and separating out these useless parts is slow, leads to significant losses, and is not well adapted to large-scale production. Separation accounts for almost 70 percent of the total gene therapy manufacturing cost. But now, researchers at MIT’s Department of Chemical Engineering and Center for Biomedical Innovation have found a way to greatly improve that separation process.

The findings are described in the journal ACS Nano, in a paper by MIT Research Scientist Vivekananda Bal, Edward R. Gilliland Professor Richard Braatz, and five others.

“Since 2017, there have been around 10,000 clinical trials of gene therapy drugs,” Bal says.

» Read More